Brandon Capital won AIC's Venture Capital Investment Deal of the Year Award 2021 for its investment in innovative biotech company, Longas Technologies. The Awards were held in Sydney and celebrated the significant role that Australia's $37 billion private capital industry plays in creating new jobs and industries.

MinterEllison acted on the establishment, funding and exit of Longas Technologies, Brandon Capital's DNA sequencing business.

"This is well-deserved recognition for an innovative and significant investment," said James Hutton, partner. "I'm immensely proud of the MinterEllison team who worked on the transaction and the significant role we played."

In a recent report by MinterEllison, Australian private capital investment outlook report, healthcare is identified as a sector offering the most attractive opportunities whilst remaining resilient to downside risk. The COVID-19 pandemic helped to emphasise how crucial well-funded, responsive healthcare systems are for the functioning of societies and economies.

MinterEllison has a long standing reputation in advising clients and investors in the life sciences sector, and venture capital investments. Advice on this transaction is another example of MinterEllison's market-leading work in healthcare.